Revised Definition of Pulmonary Hypertension and Approach to Management: A Clinical Primer
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The definition of pulmonary hypertension (PH) has changed recently based, in part, on contemporary outcome data and to focus on early disease detection. Now, PH includes patients with mean pulmonary artery pressure >20 mm Hg measured by right heart catheterization. In contrast to the classical era, pulmonary vascular resistance >2.0 Wood units is also used for diagnosis and prognostication. These lowered thresholds aim to identify patients early in the disease course, which is important because delay to diagnosis of PH is common and linked to elevated morbidity and shortened lifespan. This clinical primer highlights key changes in diagnosis and approach to PH management, focusing on concepts that are likely to be encountered frequently in general practice. Specifically, this includes hemodynamic assessment of at‐risk patients, pharmacotherapeutic management of pulmonary arterial hypertension, approach to PH in patients with heart failure with preserved ejection fraction, and newly established indications for early referral to PH centers to prompt comanagement of patients with pulmonary vascular disease experts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empagliflozin in heart failure with a preserved ejection fraction
Anker, S. D., Butler, J., Filippatos, G., Ferreira, J. P., Bocchi, E., Böhm, M., Brunner–La Rocca, H.-P., Choi, D.-J., Chopra, V., Chuquiure-Valenzuela, E., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107038 · Cited by 4,874
Harrison's principles of internal medicine
(2008) · Choice Reviews Online · doi:10.5860/choice.46-0330 · Cited by 3,083
Barst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,698
Benza, R. L., Miller, D. P., Gomberg-Maitland, M., Frantz, R. P., Foreman, A. J., Coffey, C. S., Frost, A., Barst, R. J., Badesch, D. B., Elliott, C. G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.898122 · Cited by 1,547
Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
Sitbon, O., Humbert, M., Jaïs, X., Ioos, V., Hamid, A. M., Provencher, S., Garcia, G., Parent, F., Hervé, P., & Simonneau, G. (2005) · Circulation · doi:10.1161/circulationaha.104.488486 · Cited by 1,255
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
Galiè, N., Barberà, J. A., Frost, A. E., Ghofrani, H.-A., Hoeper, M. M., McLaughlin, V. V., Peacock, A. J., Simonneau, G., Vachiery, J.-L., Grünig, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413687 · Cited by 1,182
Tricuspid Annular Displacement Predicts Survival in Pulmonary Hypertension
Forfia, P. R., Fisher, M. R., Mathai, S. C., Housten-Harris, T., Hemnes, A. R., Borlaug, B. A., Chamera, E., Corretti, M. C., Champion, H. C., Abraham, T. P., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-547oc · Cited by 1,090
Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review
Kovacs, G., Berghold, A., Scheidl, S., & Olschewski, H. (2009) · European Respiratory Journal · doi:10.1183/09031936.00145608 · Cited by 1,057
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
Boucly, A., Weatherald, J., Savale, L., Jaïs, X., Cottin, V., Prevot, G., Picard, F., de Groote, P., Jevnikar, M., Bergot, E., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00889-2017 · Cited by 697
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Waxman, A., Restrepo-Jaramillo, R., Thenappan, T., Ravichandran, A., Engel, P., Bajwa, A., Allen, R., Feldman, J., Argula, R., Smith, P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2008470 · Cited by 666
Portopulmonary hypertension and hepatopulmonary syndrome
Hoeper, M. M., Krowka, M. J., & Strassburg, C. P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16107-2 · Cited by 504
Maron, B. A., Hess, E., Maddox, T. M., Opotowsky, A. R., Tedford, R. J., Lahm, T., Joynt, K. E., Kass, D. J., Stephens, T., Stanislawski, M. A., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.020207 · Cited by 403
Self-citationUpfront triple combination therapy in pulmonary arterial hypertension: a pilot study
Sitbon, O., Jaïs, X., Savale, L., Cottin, V., Bergot, E., Macari, E. A., Bouvaist, H., Dauphin, C., Picard, F., Bulifon, S., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00116313 · Cited by 382
Olsson, K. M., Delcroix, M., Ghofrani, H. A., Tiede, H., Huscher, D., Speich, R., Grünig, E., Staehler, G., Rosenkranz, S., Halank, M., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.004526 · Cited by 372
Benza, R. L., Kanwar, M. K., Raina, A., Scott, J. V., Zhao, C. L., Selej, M., Elliott, C. G., & Farber, H. W. (2021) · Chest · doi:10.1016/j.chest.2020.08.2069 · Cited by 341
Maron, B. A., Brittain, E. L., Hess, E., Waldo, S. W., Barón, A. E., Huang, S., Goldstein, R. H., Assad, T. R., Wertheim, B. M., Alba, G. A., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30317-9 · Cited by 312
Self-citationREVEAL: a contemporary US pulmonary arterial hypertension registry
McGoon, M. D., & Miller, D. P. (2012) · European Respiratory Review · doi:10.1183/09059180.00008211 · Cited by 271
Pulmonary vascular resistances during exercise in normal subjects: a systematic review
Kovacs, G., Olschewski, A., Berghold, A., & Olschewski, H. (2012) · European Respiratory Journal · doi:10.1183/09031936.00008611 · Cited by 250
Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality
Douschan, P., Kovacs, G., Avian, A., Foris, V., Gruber, F., Olschewski, A., & Olschewski, H. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201706-1215oc · Cited by 215
Macitentan in pulmonary hypertension due to left ventricular dysfunction
Vachiéry, J.-L., Delcroix, M., Al-Hiti, H., Efficace, M., Hutyra, M., Lack, G., Papadakis, K., & Rubin, L. J. (2018) · European Respiratory Journal · doi:10.1183/13993003.01886-2017 · Cited by 207
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances
Maron, B. A., Abman, S. H., Elliott, C. G., Frantz, R. P., Hopper, R. K., Horn, E. M., Nicolls, M. R., Shlobin, O. A., Shah, S. J., Kovacs, G., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202012-4317so · Cited by 202
Self-citationHsu, S., Kokkonen-Simon, K. M., Kirk, J. A., Kolb, T. M., Damico, R. L., Mathai, S. C., Mukherjee, M., Shah, A. A., Wigley, F. M., Margulies, K. B., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033147 · Cited by 153
Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension
Zamanian, R. T., Hedlin, H., Greuenwald, P., Wilson, D. M., Segal, J. I., Jorden, M., Kudelko, K., Liu, J., Hsi, A., Rupp, A., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201705-0943oc · Cited by 142
Threshold of Pulmonary Hypertension Associated With Increased Mortality
Strange, G. A., Stewart, S., Celermajer, D. S., Prior, D., Scalia, G. M., Marwick, T. H., Gabbay, E., Ilton, M. K., Joseph, M. X., Codde, J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.482 · Cited by 138
Huston, J., Maron, B. A., French, J. K., Huang, S., Thayer, T. E., Farber‐Eger, E. H., Wells, Q. S., Choudhary, G., Hemnes, A. R., & Brittain, E. L. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.3345 · Cited by 130
Self-citationMaron, B. A., & Galiè, N. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.4471 · Cited by 129
Self-citationXanthouli, P., Jordan, S., Milde, N., Marra, A. M., Blank, N., Egenlauf, B., Gorenflo, M., Harutyunova, S., Lorenz, H., Nagel, C., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216476 · Cited by 112
Lack of a Tricuspid Regurgitation Doppler Signal and Pulmonary Hypertension by Invasive Measurement
O'Leary, J. M., Assad, T. R., Xu, M., Farber‐Eger, E., Wells, Q. S., Hemnes, A. R., & Brittain, E. L. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009362 · Cited by 103
Berry, N. C., Agarwal, M. A., Oldham, W. M., Stephens, T. E., Goldstein, R. H., Waxman, A. B., Tracy, J. A., Leary, P. J., Leopold, J. A., Kinlay, S., et al. (2015) · Pulmonary Circulation · doi:10.1086/683815 · Cited by 89
Self-citationRisk assessment in pulmonary arterial hypertension: Insights from the GRIPHON study
Sitbon, O., Chin, K., Channick, R. N., Benza, R. L., Scala, L. D., Gaine, S., Ghofrani, H. A., Lang, I. M., McLaughlin, V. V., Preiss, R., et al. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.12.013 · Cited by 75
Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension
Sitbon, O., Cottin, V., Canuet, M., Clerson, P., Gressin, V., Perchenet, L., Bertoletti, L., Bouvaist, H., Picard, F., Prévôt, G., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00673-2020 · Cited by 68
Clinical Profile and Underdiagnosis of Pulmonary Hypertension in US Veteran Patients
Maron, B. A., Choudhary, G., Khan, U. A., Jankowich, M. D., McChesney, H., Ferrazzani, S. J., Gaddam, S., Sharma, S. C., Opotowsky, A. R., Bhatt, D. L., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000091 · Cited by 67
Self-citationRedefining pulmonary hypertension
Maron, B. A., Brittain, E. L., Choudhary, G., & Gladwin, M. T. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30498-8 · Cited by 59
Self-citationJankowich, M. D., Maron, B. A., & Choudhary, G. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00072-2 · Cited by 57
Self-citationHassan, H. J., Naranjo, M., Ayoub, N., Housten, T., Hsu, S., Balasubramanian, A., Simpson, C. E., Damico, R. L., Mathai, S. C., Kolb, T. M., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202204-0731oc · Cited by 53
McLaughlin, V. V., Channick, R. N., Marco, T. D., Farber, H. W., Gaine, S., Galiè, N., Krasuski, R. A., Preston, I. R., Souza, R., Coghlan, G., et al. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.10.043 · Cited by 47
Normal and Abnormal Relationships of Pulmonary Artery to Wedge Pressure During Exercise
Bentley, R. F., Barker, M., Esfandiari, S., Wright, S. P., Valle, F. H., Granton, J. T., & Mak, S. S. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016339 · Cited by 38
Finding Pulmonary Arterial Hypertension—Switching to Offense to Mitigate Disease Burden
Maron, B. A., & Humbert, M. J. C. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.0011 · Cited by 29
Self-citationMaron, B. A., Kleiner, D. E., Arons, E., Wertheim, B. M., Sharma, N., Haley, K. J., Samokhin, A. O., Rowin, E. J., Maron, M. S., Rosing, D. R., et al. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.09.040 · Cited by 28
Self-citationChronic Thromboembolic Pulmonary Hypertension: the Bedside
Matusov, Y. P., Singh, I., Yu, Y.-R. A., Chun, H. J., Maron, B. A., Tapson, V. F., Lewis, M. I., & Rajagopal, S. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01573-5 · Cited by 15
Self-citationJohnson, S. W., Finlay, L., Mathai, S. C., Goldstein, R. H., & Maron, B. A. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12126 · Cited by 12
Self-citation
Cited by
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges
Yuan, X., Ruan, W., Bobrow, B., Carmeliet, P., & Eltzschig, H. K. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00848-6 · Cited by 245
“Pulmonary hypertension is defined by a mean pulmonary artery pressure higher than 20 mmHg 192 and is characterized by increased pulmonary vascular resistance caused by aberrant proliferation of endothelial cells and pulmonary artery smooth muscle cells, extracellular matrix deposition and…”
Pulmonary Hypertension: A Contemporary Review
Johnson, S., Sommer, N., Cox-Flaherty, K., Weissmann, N., Ventetuolo, C. E., & Maron, B. A. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202302-0327so · Cited by 190
Self-citation
Metadata
- Authors
- Maron, B. A.
- Venue
- Journal of the American Heart Association
- Published
- 2023-04-18
- Volume
- 12
- Issue
- 8
- Pages
- e029024-e029024
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W4362692997
- Cited by
- 213
- References
- 41
- FWCI
- 33.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.